Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SNYR
stocks logo

SNYR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax
Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is 7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is 7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.870
sliders
Low
7.00
Averages
7.00
High
7.00
Current: 1.870
sliders
Low
7.00
Averages
7.00
High
7.00
Roth Capital
Sean McGowan
Buy
downgrade
$10 -> $7
2025-11-14
Reason
Roth Capital
Sean McGowan
Price Target
$10 -> $7
2025-11-14
downgrade
Buy
Reason
Roth Capital analyst Sean McGowan lowered the firm's price target on Synergy CHC to $7 from $10 and keeps a Buy rating on the shares. The company made good progress during Q3, broadening its distribution footprint for both supplements and beverages and continuing to expand geographically, though its results came up short of expectations due in part to cash being tight prior to the company's recent equity raise, the analyst tells investors in a research note. Roth adds however that Synergy now has the capital needed to post significant growth in 2026.
Roth MKM
Sean McGowan
Strong Buy
Initiates
$10
2025-01-21
Reason
Roth MKM
Sean McGowan
Price Target
$10
2025-01-21
Initiates
Strong Buy
Reason
Roth MKM analyst Sean McGowan initiated coverage of Synergy CHC with a Buy rating and $10 price target. In 2023, the company had successfully trialed Focus Factor RTD beverage in Costco-Texas, and more recently, it had a trial run in Costco-Canada with similarly encouraging results, the analyst tells investors in a research note. Roth contends that the combination of growth in Focus Factor Original and the launch this quarter of Focus Factor RTD will produce strong revenue and Adjusted EBITDA growth.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Synergy CHC Corp (SNYR.O) is 0.00, compared to its 5-year average forward P/E of 0.63. For a more detailed relative valuation and DCF analysis to assess Synergy CHC Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.63
Current PE
0.00
Overvalued PE
2.77
Undervalued PE
-1.51

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
4.01
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
6.50
Undervalued EV/EBITDA
1.53

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.43
Current PS
0.00
Overvalued PS
0.69
Undervalued PS
0.17
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

SNYR News & Events

Events Timeline

(ET)
2025-11-18
09:30:20
Synergy CHC Welcomes Five New Direct Store Delivery Partners
select
2025-11-13 (ET)
2025-11-13
08:12:41
Synergy CHC Announces Q3 Earnings Per Share of 1 Cent Compared to 11 Cents Last Year
select
2025-11-05 (ET)
2025-11-05
08:15:20
Synergy CHC Forms Strategic Distribution Alliance with C&M Sales
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
11-18Newsfilter
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor Functional Beverage Distribution to Ten States with Addition of Five New Direct Store Delivery Partners

  • Expansion of Distribution: Synergy CHC Corp. has added five new Direct Store Delivery (DSD) partners, increasing the retail distribution of its FOCUSfactor Ready-to-Drink beverages across ten U.S. states, including Alaska, New York, Wisconsin, Virginia, and Pennsylvania.

  • Strategic Partnerships: The new partners include established distributors like The Sheehan Family Companies, Craft Beer Guild, Beechwood Distributors, Specialty Beverage, Bill's Distributing, and Mid-State Beverage Co., all of which will sell the full FOCUSfactor RTD portfolio.

  • Growth Strategy: This expansion is part of Synergy's strategy to build a comprehensive DSD network across all 50 states, with plans for further partnerships and market expansions expected in the near future.

  • Product Overview: FOCUSfactor is a clinically studied brain health supplement and functional beverage line, with established distribution in major retailers and a focus on accelerating growth in both domestic and international markets.

[object Object]
Preview
4.0
11-15Benzinga
Roth Capital Reaffirms Buy Rating on Synergy CHC, Reduces Price Target to $7

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters for its users.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, sharing strategies and information.

  • Market Winning Tools: Benzinga Pro is designed to help traders gain an edge in the stock market with accurate intelligence.

[object Object]
Preview
9.5
11-13Newsfilter
Synergy CHC Corp. Announces Financial Results for Q3 2025, Marking Its Eleventh Straight Quarter of Profitability

  • Financial Performance: Synergy CHC Corp. reported a revenue increase to $8.0 million for Q3 2025, marking a 12.4% growth from the previous year, alongside a gross margin expansion to 70.9%. However, net income decreased to $125.3 thousand compared to $783.6 thousand in Q3 2024.

  • Strategic Partnerships: The company has expanded its retail presence through partnerships with major retailers like Kroger and Wakefern, enhancing distribution for its FOCUSfactor products across various channels in North America.

  • Capital and Growth Initiatives: Synergy completed a $4.4 million public offering in August 2025, providing additional working capital to support growth initiatives, including the launch of its beverage division.

  • Recognition and Leadership: FOCUSfactor was named the #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026, reflecting the brand's strong market position and consumer trust, while the company appointed former Costco executive Teresa Thompson to its Board of Directors to bolster retail expertise.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Synergy CHC Corp (SNYR) stock price today?

The current price of SNYR is 1.87 USD — it has increased 1.36 % in the last trading day.

arrow icon

What is Synergy CHC Corp (SNYR)'s business?

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

arrow icon

What is the price predicton of SNYR Stock?

Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is 7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Synergy CHC Corp (SNYR)'s revenue for the last quarter?

Synergy CHC Corp revenue for the last quarter amounts to 8.01M USD, increased 12.40 % YoY.

arrow icon

What is Synergy CHC Corp (SNYR)'s earnings per share (EPS) for the last quarter?

Synergy CHC Corp. EPS for the last quarter amounts to 0.01 USD, decreased -90.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Synergy CHC Corp (SNYR)'s fundamentals?

The market is revising No Change the revenue expectations for Synergy CHC Corp. (SNYR) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -19.40%.
arrow icon

How many employees does Synergy CHC Corp (SNYR). have?

Synergy CHC Corp (SNYR) has 21 emplpoyees as of December 05 2025.

arrow icon

What is Synergy CHC Corp (SNYR) market cap?

Today SNYR has the market capitalization of 21.04M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free